ArticlebioRxiv : the preprint server for biology2025
An Interpretable Deep Learning Framework for Biomarker Discovery in Complex Disease Survival Outcomes.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Identification of important biomarkers associated with complex disease survival outcomes is fundamental for gaining an in-depth understanding of disease mechanisms and advancing precision medicine in conditions such as cancer and cardiovascular disorders. However, these tasks are complicated by the unique nature of time-to-event data, which captures both the occurrence and timing of clinical events. Notably, complex associations such as the non-linear and non-additive biomarker interactions and the high-dimensionality challenge conventional survival data modeling approaches. To address these difficulties, we propose SurvDNN, an enhanced deep neural network framework specifically designed for survival outcomes modeling. SurvDNN incorporates a bootstrapping-based regularization strategy to mitigate overfitting and a novel stability-driven filtering algorithm to improve model robustness. To enable interpretable biomarker discovery, we extend the Permutation-based Feature Importance Test (PermFIT) to survival settings, allowing rigorous quantification of individual biomarker contributions under complex biomarker-outcome associations. Through extensive simulations and applications to real-world datasets, SurvDNN consistently outperforms existing machine learning approaches in both biomarker identification and predictive accuracy. Our results demonstrate the potential of SurvDNN coupled with PermFIT as an interpretable, robust, and powerful tool for biomarker-driven survival modeling in complex diseases. An open-source R package implementing SurvDNN is publicly available on GitHub (https://github.com/BZou-lab/SurvDNN).
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.